Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245)

Motoshi Suzuki, Ke Cao, Seiichi Kato, Yuji Komizu, Naoki Mizutani, Kouji Tanaka, Chinatsu Arima, Mei Chee Tai, Kiyoshi Yanagisawa, Norie Togawa, Takahiro Shiraishi, Noriyasu Usami, Tetsuo Taniguchi, Takayuki Fukui, Kohei Yokoi, Keiko Wakahara, Yoshinori Hasegawa, Yukiko Mizutani, Yasuyuki Igarashi, Jin ichi InokuchiSoichiro Iwaki, Satoshi Fujii, Akira Satou, Yoko Matsumoto, Ryuichi Ueoka, Keiko Tamiya-Koizumi, Takashi Murate, Mitsuhiro Nakamura, Mamoru Kyogashima, Takashi Takahashi

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

The corresponding author recently notified the JCI that the patient data presented in Figure 1B were not correct. Analysis of the correct patient data set does not show a significant difference in CERS6expression in human lung adenocarcinomas with positive invasive growth (definite) compared with those with negligible invasive growth or without invasive growth (focal/none). The Editors have requested an institutional investigation into this matter, and we will inform our readers of the outcome when the investigation is complete.

Original languageEnglish
Pages (from-to)3464
Number of pages1
JournalJournal of Clinical Investigation
Volume129
Issue number8
DOIs
Publication statusPublished - 01-08-2019

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245)'. Together they form a unique fingerprint.

Cite this